NYSE : RA
-$0.07 (-0.54%)
| Source | Headline |
|---|---|
|
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata gurufocus.com - 2026-06-29 04:00:00 |
|
Brookfield Real Assets Income Fund Inc. Declares Q3 2026 Distribution Schedule
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund's monthly distributions for July, August and September 2026. globenewswire.com - 2026-06-26 16:58:00 |
|
Brookfield Real Assets Income Fund Inc. Announces Portfolio Management Team Change
NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (the “Fund”) (NYSE: RA) today announced upcoming portfolio management changes at Oaktree Fund Advisors, LLC (“Oaktree”), the sub-adviser responsible for managing the Fund's securitized credit allocation. globenewswire.com - 2026-06-08 13:19:00 |
|
Organon to Present New Research on Access and Value at ISPOR 2026
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will present data acros gurufocus.com - 2026-05-15 08:00:00 |
|
RA: NAV Erosion Will Continue Even When Interest Rates Decline
Brookfield Real Assets Income Fund maintains a high 10.9% yield but suffers from persistent NAV erosion due to unsustainable dividend payouts. RA's net investment income consistently fails to cover distributions, forcing reliance on net realized gains and return of capital, which undermines NAV stability. The fund's heavy allocation to below-investment-grade, floating-rate credit and use of leverage heighten risk, especially in a high-rate environment. seekingalpha.com - 2026-04-23 21:15:26 |